CNSP Company Profile and Key Details
CNS Pharmaceuticals, Inc.
CNSP Stock Price Chart
Stock Price Today
CNS Pharmaceuticals, Inc. (CNSP) stock declined over -2.10%, trading at $0.09 on NASDAQ, down from the previous close of $0.10. The stock opened at $0.09, fluctuating between $0.09 and $0.10 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, an anthracycline that is in Phase I and II clinical trials that is used for the treatment of glioblastoma multiforme. It has license agreements with Houston Pharmaceuticals, Inc. and The University of Texas M.D. Anderson Cancer Center, as well as Animal Life Sciences, LLC; and a development agreement with WPD Pharmaceuticals Inc., as well as a collaboration agreement with Reata Pharmaceuticals, Inc. The company was incorporated in 2017 and is based in Houston, Texas.
Company Information
| Employees | 3 |
| Beta | 1.05 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) stock price is $0.09 in the last trading session. During the trading session, CNSP stock reached the peak price of $0.10 while $0.09 was the lowest point it dropped to. The percentage change in CNSP stock occurred in the recent session was -2.1% while the dollar amount for the price change in CNSP stock was -$0.00.
The NASDAQ listed CNSP is part of Biotechnology industry that operates in the broader Healthcare sector. CNS Pharmaceuticals, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Christopher S. Downs C.P.A., CTP, FP&A
Chief Financial Officer
Mr. John Michael Climaco Esq., J.D.
Chief Executive Officer, Pres & Director
Dr. Donald H. Picker Ph.D.
Chief Scientific Officer
Mr. Christopher S. Downs CPA, CTP, FP&A
Chief Financial Officer
Dr. Waldemar Priebe Ph.D.
Co-Founder, Founding Scientist & Chairman of Scientific Advisory Board
Dr. Sandra L. Silberman M.D., Ph.D.
Chief Medical Officer of New Products
CNSP's closing price is 13.21% higher than its 52-week low of $0.08 where as its distance from 52-week high of $23.90 is -99.6%.
Number of CNSP employees currently stands at 3.
Official Website of CNSP is: https://www.cnspharma.com
CNSP could be contacted at phone 800 946 9185 and can also be accessed through its website. CNSP operates from 2100 West Loop South, Houston, TX 77027, United States.
CNSP stock volume for the day was 6.75M shares. The average number of CNSP shares traded daily for last 3 months was 15.46M.
The market value of CNSP currently stands at $5.35M with its latest stock price at $0.09 and 57.49M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com